
Starting with Status
Small and medium-sized enterprises (SMEs) are the backbone of Europe’s economy, representing 99% of all EU businesses. SMEs are often innovative…
In light of JIA Awareness Month, its treatments, its stigma, and more, we spoke with Dr. Johnny Peppers, Executive Director of Drug Development for…
Over the past several months, participants in PRA Health Sciences’ Health Harmony COVID-19 Monitoring Program have had vital information about…
Small and medium-sized enterprises (SMEs) are the backbone of Europe’s economy, representing 99% of all EU businesses. SMEs are often innovative…
This article describes remote patient monitoring, how it improves clinical trial success, and how it can continue to be improved for better…
As a woman of color (WOC) and first-born daughter of immigrants, my life has always had its set of challenges. My parents didn’t go to…
The COVID-19 pandemic poses a critical challenge to individuals, caregivers and healthcare systems worldwide. This challenge extends directly to the…
Scientific advice is a regulatory process expected to, “facilitate timely access to safe and efficacious medicinal products to patients and users of…
In the third week of February, we are bringing you news of funding into a major research initiative launching in the UK to help understand the…
Encephalitis is a rare type of infection that has a severe acute stage but can have a lasting long-term effect on patients and their families. For…
In light of American Heart Month, find out the current research on heart disease and where we’re going.
The ebb and flow of a pharmaceutical or biotechnology company’s clinical development portfolio places an emphasis on ensuring that the resources…
Download 4 practical tools for patient-centric trial development including: Patient Involvement Value Dossier, Patient Centric Protocol Risk…